Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Rheumatology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Rheumatology

Journal Scan / Research · September 30, 2022

Risk Factors for Systemic Lupus Erythematosus in Patients With Immune Thrombocytopenia

Arthritis Research & Therapy


Additional Info

Arthritis Research & Therapy
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia
Arthritis Res. Ther. 2022 Sep 06;24(1)213, SM Ahn, EJ Choi, JS Oh, YG Kim, CK Lee, B Yoo, S Hong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading